To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
19 Newest Market Studies about the topic pulmonary diseases
rssIntroduction GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012" provides data on the Obstructive Pulmonary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on ...
Introduction Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) therapeutic pipeline. This report provides information on the therapeutic development for Chronic ...
GBI Research’s report, “Anesthesia and Respiratory Devices Market to 2017 - Sleep Apnea Diagnostic Systems and Portable Anesthesia Delivery Machines to be the Fastest Growing Categories” provides key data, information and analysis on the global anesthesia and respiratory devices market. The ...
TechNavio’s analysts forecast the Global Inhalation Systems market to grow at a CAGR of 6.3 percent over the period 2010–2014. One of the key factors contributing to this market growth is growing prevalence of asthma and chronic obstructive pulmonary diseases. The Global Inhalation Systems ...
Introduction Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2012', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) therapeutic pipeline. This report provides information on the therapeutic development for Chronic ...
Introduction Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, Q1 2011', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) therapeutic pipeline. This report provides information on the therapeutic development for Chronic ...
Cardiocom, LLC - Strategic SWOT Analysis Review Summary Cardiocom, LLC (Cardiocom) is a leader in providing daily remote patient monitoring and disease management solutions to the healthcare community. The company is engaged in the development, manufacture and sale of its own telehealth ...
Verona Pharma Plc (VRP) - Financial and Strategic SWOT Analysis Review Summary Verona Pharma Plc (Verona Pharma), formerly known as Isis Resources plc, is a life sciences company engaged in the research, discovery and development of therapeutic drugs for the treatment of chronic respiratory ...
Entest BioMedical Inc. (Entest), a majority owned subsidiary of Bio-Matrix Scientific Group Inc. The company is engaged in the development of stem cell therapy for the treatments of chronic obstructive pulmonary disease (COPD), testing procedures, cancer immuno-therapies and stem cell ...
Galapagos NV (Galapagos) is a publicly held research focused biopharmaceutical company. It is engaged in discovery and development of disease modifying drugs. The company develops GLPG0259 that targets protein kinase MAPKAPK5, as its leading drug candidate for the under initial stages of ...
